Cantor Fitzgerald Reiterates Overweight on Merck & Co, Maintains $155 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Louise Chen reiterates an Overweight rating on Merck & Co (NYSE:MRK) and maintains a $155 price target.
June 18, 2024 | 12:08 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald analyst Louise Chen reiterates an Overweight rating on Merck & Co (NYSE:MRK) and maintains a $155 price target.
The reiteration of an Overweight rating and a maintained price target of $155 by a reputable analyst from Cantor Fitzgerald is a positive signal for investors. This could lead to increased investor confidence and potentially a short-term price increase for MRK.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100